Formulary Committee Adds Cost Rationale To Drug Reviews
Vol: 29 | No: 9 | Published on: May 8, 2019
Do cost considerations have a role to play in selecting drugs for California’s pharmacy formulary? The debate has started. What are the initial results? Get the story here.
Read More...
This content is for premium subscribers. To read please login or subscribe below.
